DAPAgliflozin for Renal Protection in Heart Transplant Recipients
DAPAgliflozin for Renal Protection in Heart Transplant Recipients
Active, not recruiting · NCT05321706 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DAPAgliflozin for Renal Protection in Heart Transplant Recipients | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Phase 3 | 2026-07-01 | NCT05321706 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aarhus University Hospital | 297 |
| Erasmus Medical Center | 271 |
| Karolinska University Hospital | 181 |
| Oslo University Hospital | 327 |
| Sahlgrenska University Hospital | 158 |
| Skane University Hospital | 71 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Erasmus Medical Center | Rotterdam | Netherlands | 36 |
| Karolinska University Hospital | Stockholm | Sweden | 87 |
| Oslo University Hospital, Rikshospitalet | Oslo | Norway | 1 |
| Skane University Hospital | Lund | Sweden | 5 |
| University Medical Center Groningen | Groningen | Netherlands | 66 |
| University Medical Center Utrecht | Utrecht | Netherlands | 10 |